“…Angiolymphatic invasion has been reported as an adverse indicator for both SLN positivity and overall survival in patients with melanoma. 7,8,25,26 Body site location also was a significant predictor of SLN positivity in our model. Location of the primary melanoma on the trunk or lower extremities doubled the odds of SLN positivity (OR, 1.92) compared with location on the head/neck or upper extremities.…”
Section: Discussionmentioning
confidence: 70%
“…2,3 Other factors that have been examined variably include patient age, anatomic location, mitotic rate, ulceration, angiolymphatic invasion, lymphangiogenesis, Clark level, vertical growth phase, tumor-infiltrating lymphocytes, regression, and satellitosis. [5][6][7][8][9][10] Differences in study design and data collected no doubt explain some of the variation in factors that reportedly are associated significantly with positive SLN status.…”
“…Angiolymphatic invasion has been reported as an adverse indicator for both SLN positivity and overall survival in patients with melanoma. 7,8,25,26 Body site location also was a significant predictor of SLN positivity in our model. Location of the primary melanoma on the trunk or lower extremities doubled the odds of SLN positivity (OR, 1.92) compared with location on the head/neck or upper extremities.…”
Section: Discussionmentioning
confidence: 70%
“…2,3 Other factors that have been examined variably include patient age, anatomic location, mitotic rate, ulceration, angiolymphatic invasion, lymphangiogenesis, Clark level, vertical growth phase, tumor-infiltrating lymphocytes, regression, and satellitosis. [5][6][7][8][9][10] Differences in study design and data collected no doubt explain some of the variation in factors that reportedly are associated significantly with positive SLN status.…”
“…Clinical adverse factors include increasing age, male, location of the lesion, and metastasis. Moreover, regional lymph node (Sentinel) status has emerged as an accurate method for evaluating the draining lymph node basin, allowing for the generation of valuable prognostic information (Mraz-Gernhard et al, 1998). Sentinel lymph node biopsy became a compulsory phase for patients with tumour thickness > 1 mm (Patnana, et al, 2011;Petrescu, et al, 2010).…”
Section: Routine Diagnostic Methods and Prognostic Factorsmentioning
“…Some studies have correlated the frequency of angiolymphatic invasion with increasing depth and level of tumor invasion, 59 while others have shown vascular invasion to be a significant predictor of metastasis 90 or of reduced survival. 11 It is perhaps the low frequency of this finding that prevented its emergence as an independent prognostic variable in many earlier series, but more recent data has shown a reduced survivorship of some 40% over 8 years when angioinvasion is demonstrated in primary tumors in vertical growth phase.…”
Section: Blood Vessel and Lymphatic Invasionmentioning
Since the 1960s, the clinical characteristics of melanoma, its histopathology and its biological basis have been the subject of intense study at pigmented lesion clinics in North America, Europe, and Australia. More recently, the immense database of the Melanoma Committee of the American Joint Committee on Cancer (AJCC) has been exploited through complex mathematical models to measure the impact of various histologic features of primary melanomas and of sentinel lymph node deposits and to correlate these parameters with patient survival. The wealth of modern information available to pathologists and clinicians has become of vital interest to the prognostication of the individual patient with melanoma. The purpose of this review is to bring to the attention of anatomic pathologists the essential characteristics of the pathology report for primary cutaneous melanoma in the modern era.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.